Clorox CO /DE/ 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
Clorox completes the $2.25 billion acquisition of GOJO Industries and buys out P&G's stake in the Glad business while navigating a flat sales quarter.
NYSE
Clorox reports a decline in Q2 net earnings and diluted EPS, driven by lower sales and higher costs, while announcing the strategic acquisition of GOJO Industries for $2.25 billion.
NYSE
Clorox reports a significant 19% drop in net sales and diluted EPS for Q1 FY26, primarily due to ERP system transition impacts and ongoing macroeconomic pressures.
NYSE
10-Q: Clorox Reports Q3 2025 Results: Sales Dip Amid Divestitures, Margin Expansion Drives Earnings Surge
Clorox's Q3 2025 results show a decrease in net sales due to divestitures, but a significant increase in earnings driven by margin expansion and cost savings.
NYSE
Clorox's second quarter of fiscal year 2025 saw a decrease in net sales but an increase in earnings per share, influenced by divestitures, cyberattack recovery, and cost-saving measures.
NYSE
Clorox's first quarter of fiscal year 2025 shows significant improvement in sales and earnings, primarily due to recovery from a prior cyberattack and strategic divestitures.
NYSE
Clorox's Q3 results show a net loss, impacted by a cyberattack and divestiture, but gross margins improved due to pricing and cost savings.
NYSE
10-Q: Clorox Amends Executive Retirement Plan and Reports Q2 2024 Results Amidst Cyberattack Recovery
Clorox updates its executive retirement plan and releases its second quarter 2024 financial results, showing recovery from a cyberattack while navigating a complex economic environment.